PER percheron therapeutics limited

Ann: Notices received under S203D and S249D of Corporations Act, page-45

  1. 8,307 Posts.
    lightbulb Created with Sketch. 803
    yep, Totally agree with that. Gennadi should fail, but PVL may not. Gennadi is a road back to nowhere, PVL may have an interesting plan.

    From my experience micro-cap CEOs always get accused of being paid too much, it's par for the course, and even if they own plenty of stock that is certainly not a guarantee of anything either.

    Yes, Current management (and me) certainly got PVL's intentions wrong, this will have spooked them.

    I think the share price down here is great value with three serious parties vying for control, One with deep disgruntled pockets (Gennadi), One with an experienced bio-tech team (Garner) and one a listed fund manager known for turnaround stories (PVL) . Don't see that everyday
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.2¢ 1.3¢ 1.0¢ $277.9K 24.26M

Buyers (Bids)

No. Vol. Price($)
11 2273797 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 5066000 5
View Market Depth
Last trade - 16.14pm 26/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.